Arsenic exposure and DNA methylation among elderly men

Epidemiology

Volumn 23, Issue 5, 2012, Pages 668-676

  Lambrou, Angeliki ^a   Baccarelli, Andrea ^a   Wright, Robert O ^a,b   Weisskopf, Marc ^a   Bollati, Valentina ^c   Amarasiriwardena, Chitra ^b   Vokonas, Pantel ^d,e   Schwartza, Joel ^a  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF MILAN   (Italy)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

^e BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALU NUCLEOTIDE; ARSENIC; COBALAMIN; CYANOCOBALAMIN; FOLIC ACID; LONG INTERSPERSED NUCLEOTIDE ELEMENT 1; NUCLEOTIDE; PYRIDOXINE; UNCLASSIFIED DRUG;

AGED; ARTICLE; DNA METHYLATION; EXPOSURE; FOLIC ACID BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; NAIL; NUTRITIONAL ASSESSMENT; POPULATION RESEARCH; PRIORITY JOURNAL; TOE NAIL;

AGED; AGED, 80 AND OVER; ALU ELEMENTS; ARSENIC; BIOLOGICAL MARKERS; COHORT STUDIES; DNA METHYLATION; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL POLLUTANTS; FOLIC ACID; HUMANS; LINEAR MODELS; LONG INTERSPERSED NUCLEOTIDE ELEMENTS; MALE; MASS SPECTROMETRY; NAILS; VITAMIN B 12; VITAMIN B 6;

EID: 84864883833     PISSN: 10443983     EISSN: 15315487     Source Type: Journal    
DOI: 10.1097/EDE.0b013e31825afb0b     Document Type: Article

References (52)

1. United States Environmental Protection Agency. Comprehensive Environmental Response, Compensation, and Liability Act (CERCLA) Priority List of Hazardous Substances. Available at: http://www.epa.gov/superfund/health/ contaminants/index.htm. Accessed February 20, 2010.
2. Schuhmacher-Wolz U, Dieter HH, Klein D, Schneider K. Oral exposure to inorganic arsenic: evaluation of its carcinogenic and non-carcinogenic effects. Crit Rev Toxicol. 2009;39:271-298.
3. Wang CH, Hsiao CK, Chen CL, et al. A review of the epidemiologic literature on the role of environmental arsenic exposure and cardiovascular diseases. Toxicol Appl Pharmacol. 2007;222:315-326.
4. Agency for Toxic Substances and Disease Registry (ATSDR). Toxicological Profile for Arsenic. Atlanta, GA: US Department of Health and Human Services, Public Health Service; 2007.
5. Pilsner JR, Liu X, Ahsan H, et al. Genomic methylation of peripheral blood leukocyte DNA: influences of arsenic and folate in Bangladeshi adults. Am J Clin Nutr. 2007;86:1179-1186.
6. Ercal N, Gurer-Orhan H, Aykin-Burns N. Toxic metals and oxidative stress part I: mechanisms involved in metal-induced oxidative damage. Curr Top Med Chem. 2001;1:529-539.
7. Chen H, Li S, Liu J, Diwan BA, Barrett JC, Waalkes MP. Chronic inorganic arsenic exposure induces hepatic global and individual gene hypomethylation: implications for arsenic hepatocarcinogenesis. Carcinogenesis. 2004;25:1779-1786.
8. Valinluck V, Tsai HH, Rogstad DK, Burdzy A, Bird A, Sowers LC. Oxidative damage to methyl-CpG sequences inhibits the binding of the methyl-CpG binding domain (MBD) of methyl-CpG binding protein 2 (MeCP2). Nucleic Acids Res. 2004;32:4100-4108.
9. Pogribny IP, Tryndyak VP, Woods CG, Witt SE, Rusyn I. Epigenetic effects of the continuous exposure to peroxisome proliferator WY-14,643 in mouse liver are dependent upon peroxisome proliferator activated receptor alpha. Mutat Res. 2007;625:62-71.
10. Hedges DJ, Deininger PL. Inviting instability: transposable elements, double-strand breaks, and the maintenance of genome integrity. Mutat Res. 2007;616:46-59.
11. Kazazian HH Jr, Goodier JL. LINE drive: retrotransposition and genome instability. Cell. 2002;110:277-280.
12. Grover D, Mukerji M, Bhatnagar P, Kannan K, Brahmachari SK. Alu repeat analysis in the complete human genome: trends and variations with respect to genomic composition. Bioinformatics. 2004;20:813-817.
13. Yang AS, Estecio MR, Doshi K, Kondo Y, Tajara EH, Issa JP. A simple method for estimating global DNA methylation using bisulfite PCR of repetitive DNA elements. Nucleic Acids Res. 2004;32:e38.
14. Kazazian HH Jr. Mobile elements: drivers of genome evolution. Science. 2004;303:1626-1632.
15. Baccarelli A, Bollati V. Epigenetics and environmental chemicals. Curr Opin Pediatr. 2009;21:243-251.
16. Bollati V, Schwartz J, Wright R, et al. Decline in genomic DNA methylation through aging in a cohort of elderly subjects. Mech Ageing Dev. 2009;130:234-239.
17. Bollati V, Baccarelli A, Hou L, et al. Changes in DNA methylation patterns in subjects exposed to low-dose benzene. Cancer Res. 2007;67: 876-880.
18. Rusiecki JA, Baccarelli A, Bollati V, Tarantini L, Moore LE, Bonefeld-Jorgensen EC. Global DNA hypomethylation is associated with high serum-persistent organic pollutants in Greenlandic Inuit. Environ Health Perspect. 2008;116:1547-1552.
19. Marsit CJ, Karagas MR, Danaee H, et al. Carcinogen exposure and gene promoter hypermethylation in bladder cancer. Carcinogenesis. 2006;27: 112-116.
20. Chen WT, Hung WC, Kang WY, Huang YC, Chai CY. Urothelial carcinomas arising in arsenic-contaminated areas are associated with hypermethylation of the gene promoter of the death-associated protein kinase. Histopathology. 2007;51:785-792.
21. Zhang AH, Bin HH, Pan XL, Xi XG. Analysis of p16 gene mutation, deletion and methylation in patients with arseniasis produced by indoor unventilated-stove coal usage in Guizhou, China. J Toxicol Environ Health A. 2007;70:970-975.
22. Smeester L, Rager JE, Bailey KA, et al. Epigenetic changes in individuals with arsenicosis. Chem Res Toxicol. 2011;24:165-167.
23. Majumdar S, Chanda S, Ganguli B, Mazumder DN, Lahiri S, Dasgupta UB. Arsenic exposure induces genomic hypermethylation. Environ Toxicol. 2010;25:315-318.
24. Reichard JF, Schnekenburger M, Puga A. Long term low-dose arsenic exposure induces loss of DNA methylation. Biochem Biophys Res Commun. 2007;352:188-192.
25. Uthus EO, Davis C. Dietary arsenic affects dimethylhydrazine-induced aberrant crypt formation and hepatic global DNA methylation and DNA methyltransferase activity in rats. Biol Trace Elem Res. 2005;103:133-145.
26. Chanda S, Dasgupta UB, Guhamazumder D, et al. DNA hypermethylation of promoter of gene p53 and p16 in arsenic-exposed people with and without malignancy. Toxicol Sci. 2006;89:431-437.
27. Bell B, Rose CL, Damon A. The Normative Aging Study. An interdisciplinary and longitudinal study of health and aging. Aging Hum Dev. 1972;3:5-17.
28. Tucker KL, Qiao N, Scott T, Rosenberg I, Spiro A III. High homocysteine and low B vitamins predict cognitive decline in aging men: the Veterans Affairs Normative Aging Study. Am J Clin Nutr. 2005;82:627-635.
29. Willett WC, Sampson L, Stampfer MJ, et al. Reproducibility and validity of a semiquantitative food frequency questionnaire. Am J Epidemiol. 1985;122:51-65.
30. Wright RO, Schwartz J, Wright RJ, et al. Biomarkers of lead exposure and DNA methylation within retrotransposons. Environ Health Perspect. 2010;118:790-795.
31. Zhu ZZ, Hou L, Bollati V, et al. Predictors of global methylation levels in blood DNA of healthy subjects: a combined analysis. Int J Epidemiol. 2012;41:126-139.
32. Wood S. Modelling and smoothing parameter estimation with multiple quadratic penalties. J R Statist Soc B. 2000;62:413-428.
33. Fox J. Appendix to An R and S-PLUS Companion to Applied Regression. Nonparametric Regression. California: Sage Publications; 2002.
34. Madrigano J, Baccarelli A, Mittleman MA, et al. Prolonged exposure to particulate pollution, genes associated with glutathione pathways, and DNA methylation in a cohort of older men. Environ Health Perspect. 2011;119:977-982.
35. Baccarelli A, Wright RO, Bollati V, et al. Rapid DNA methylation changes after exposure to traffic particles. Am J Respir Crit Care Med. 2009;179:572-578.
36. Choi JY, James SR, Link PA, et al. Association between global DNA hypomethylation in leukocytes and risk of breast cancer. Carcinogenesis. 2009;30:1889-1897.
37. Schmid CW. Does SINE evolution preclude Alu function? Nucleic Acids Res. 1998;26:4541-4550.
38. Belancio VP, Deininger PL, Roy-Engel AM. LINE dancing in the human genome: transposable elements and disease. Genome Med. 2009; 1:97.
39. Kim M, Long TI, Arakawa K, Wang R, Yu MC, Laird PW. DNA methylation as a biomarker for cardiovascular disease risk. PLoS One. 2010;5:e9692.
40. Baccarelli A, Wright R, Bollati V, et al. Ischemic heart disease and stroke in relation to blood DNA methylation. Epidemiology. 2010;21: 819-828.
41. Benbrahim-Tallaa L, Waterland RA, Styblo M, Achanzar WE, Webber MM, Waalkes MP. Molecular events associated with arsenic-induced malignant transformation of human prostatic epithelial cells: aberrant genomic DNA methylation and K-ras oncogene activation. Toxicol Appl Pharmacol. 2005;206:288-298.
42. Pilsner JR, Liu X, Ahsan H, et al. Folate deficiency, hyperhomocysteinemia, low urinary creatinine, and hypomethylation of leukocyte DNA are risk factors for arsenic-induced skin lesions. Environ Health Perspect. 2009;117:254-260.
43. Gamble MV, Liu X, Ahsan H, et al. Folate, homocysteine, and arsenic metabolism in arsenic-exposed individuals in Bangladesh. Environ Health Perspect. 2005;113:1683-1688.
44. Karagas MR, Tosteson TD, Blum J, et al. Measurement of low levels of arsenic exposure: a comparison of water and toenail concentrations. Am J Epidemiol. 2000;152:84-90.
45. Slotnick MJ, Meliker JR, AvRuskin GA, Ghosh D, Nriagu JO. Toenails as a biomarker of inorganic arsenic intake from drinking water and foods. J Toxicol Environ Health A. 2007;70:148-158.
46. National Research Council's Subcommittee on Arsenic in Drinking Water (NRC). Arsenic in Drinking Water. Washington, DC: National Academy Press; 1999:177-192.
47. Longnecker MP. On confounded fishy results regarding arsenic and diabetes. Epidemiology. 2009;20:821-823.
48. Slotnick MJ, Nriagu JO. Validity of human nails as a biomarker of arsenic and selenium exposure: a review. Environ Res. 2006;102:125-139.
49. Chiou HY, Hsueh YM, Hsieh LL, et al. Arsenic methylation capacity, body retention, and null genotypes of glutathione S-transferase M1 and T1 among current arsenic-exposed residents in Taiwan. Mutat Res. 1997;386:197-207.
50. Mordukhovich I, Wright RO, Hu H, et al. Associations of toenail arsenic, cadmium, mercury, manganese and lead with blood pressure in the normative aging study. Environ Health Perspect. 2012;120: 98-104.
51. Mordukhovich I, Wright RO, Amarasiriwardena C, et al. Association between low-level environmental arsenic exposure and QT interval duration in a general population study. Am J Epidemiol. 2009;170:739-746.
52. Kamimura T, Miyamoto T, Harada M, Akashi K. Advances in therapies for acute promyelocytic leukemia. Cancer Sci. 2011;102:1929-1937.